Travel report on the mRNA Technology Transfer Hub Programme
10 September 2021
MPP site visit to formalise discussions around the creation of the mRNA technology transfer hub in South Africa
At the invitation of the World Health Organization and with the support of the Department of Science and Innovation of South Africa, representatives from the Medicines Patent Pool and other local and international partners of a consortium working to address the global imbalance of manufacturing capacity for COVID-19 vaccines met from 6-9 September 2021 to discuss next steps in establishing the South African mRNA technology transfer hub that will allow for greater and more diversified vaccines manufacturing capability, strengthen African regional health security and respond more equitably to the current COVID-19 pandemic and future pandemics. They also visited the Afrigen and Biovac facilities to validate conformity, compliance and alignement with the Hub concept.